Answers are grounded in this paper and cite their sources.
Some thirty years ago, methysergide was introduced as the first drug capable of preventing migraine attacks and proved to be remarkably effective [1,2]. Because many peripheral actions of serotonin were found to be antagonized by methysergide, attention was focused on circulating serotonin as a potentially important substance in the generation of headaches. However, over the years, interest in the humoral actions of serotonin waned because of a lack of supportive evidence. Today, there is an explosion of renewed interest in serotonin and headache, this time in its neurotransmitter role in the central nervous system (CNS) [3]. This progress report will focus on the lines of evidence that have led to perturbed serotonergic neurotransmission as a putative mechanism of migraine. It appears likely that the mode of action of the antimigraine drugs is stabilization of such perturbation by enhancing serotonergic neurotransmission [4].
No takes yet. Share an insight, caveat, or question.
Neil H. Raskin (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: